Granules India's Virginia Facility Achieves Flawless USFDA Inspection
Loading more articles...
Granules India's Virginia Facility Aces USFDA Inspection with Zero Observations
C
CNBC TV18•05-03-2026, 12:50
Granules India's Virginia Facility Aces USFDA Inspection with Zero Observations
•Granules India's US-based step-down subsidiary's Virginia packaging facility received an Establishment Inspection Report (EIR) with No Action Indicated (NAI) status from USFDA.
•The inspection of Granules Consumer Health LLC's Manassas, Virginia facility occurred between December 1 and December 3, 2025.
•This marks the facility's second consecutive USFDA inspection with zero observations, following a similar outcome in March 2023.
•The facility serves as a packaging and distribution hub for OTC and prescription medicines, processing controlled substances.
•Chairman Krishna Prasad Chigurupati stated the outcome reflects the company's focus on quality, safety, and regulatory compliance.
